Redhawk Wealth Advisors Inc. Acquires 1,175 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• Redhawk Wealth Advisors Inc. increased its position in UnitedHealth Group by 184.5% during the second quarter, owning a total of 1,812 shares worth $565,000.
• UnitedHealth Group reported earnings per share of $4.08 for the last quarter, missing expectations and experiencing a revenue of $111.62 billion, which was slightly below analysts' projections.
• The company declared a quarterly dividend of $2.21 per share, with a yield of 2.6%, scheduled for payment on September 23rd.

Redhawk Wealth Advisors Inc. lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 184.5% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 1,812 shares of the healthcare conglomerate's stock after purchasing an additional 1,175 shares during the period. Redhawk Wealth Advisors Inc.'s holdings in UnitedHealth Group were worth $565,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of UNH. Bayforest Capital Ltd increased its position in UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after purchasing an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd raised its stake in shares of UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after buying an additional 50 shares during the last quarter. Copia Wealth Management acquired a new stake in UnitedHealth Group during the 4th quarter worth $42,000. IAG Wealth Partners LLC acquired a new stake in UnitedHealth Group during the 1st quarter worth $42,000. Finally, Investment Management Corp VA ADV acquired a new stake in UnitedHealth Group during the 4th quarter worth $44,000. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

Shares of UNH stock traded up $1.90 on Friday, reaching $336.72. The stock had a trading volume of 13,528,738 shares, compared to its average volume of 13,748,202. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The firm's 50-day moving average is $295.67 and its two-hundred day moving average is $364.42. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a market capitalization of $304.96 billion, a price-to-earnings ratio of 14.59, a P/E/G ratio of 2.20 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter last year, the company posted $6.80 EPS. The firm's revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's payout ratio is currently 38.30%.

Analyst Ratings Changes

Several brokerages have commented on UNH. Wall Street Zen downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $440.00 target price on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Barclays increased their price objective on shares of UnitedHealth Group from $337.00 to $352.00 and gave the stock an "overweight" rating in a research report on Thursday, September 4th. Royal Bank Of Canada cut their target price on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 30th. Finally, Morgan Stanley increased their target price on shares of UnitedHealth Group from $325.00 to $395.00 and gave the stock an "overweight" rating in a report on Friday, September 12th. Sixteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, UnitedHealth Group presently has an average rating of "Moderate Buy" and an average target price of $358.95.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.